Vulvovaginites recorrentes em mulheres adultas: fatores associados, abordagens terapêuticas e estratégias preventivas - Uma revisão integrativa.
Recurrent vulvovaginitis represents a significant challenge to women's health due to persistent symptoms, therapeutic difficulties, and its impact on quality of life. This study aimed to analyze scientific evidence on factors associated with recurrent vulvovaginitis in adult women, therapeutic approaches, and preventive strategies. An integrative literature review was conducted using a descriptive design and qualitative approach, based on studies retrieved from the PubMed/MEDLINE and SciELO databases, covering publications from 2021 to 2026. A total of 28 original studies were selected and analyzed according to three thematic categories: factors associated with recurrence, therapeutic approaches, and preventive strategies. The findings indicated that recurrent bacterial vaginosis is primarily associated with persistent vaginal dysbiosis and changes in the vaginal microbiota, whereas recurrent vulvovaginal candidiasis involves factors such as biofilm formation, antifungal resistance, and individual immune response characteristics. Regarding treatment, certain maintenance regimens demonstrated beneficial outcomes, although alternative interventions still present limitations concerning evidence of efficacy. Preventive strategies emphasized the importance of accurate diagnosis, clinical follow-up, and health education. It was concluded that the management of recurrent vulvovaginitis requires an individualized, evidence-based approach aimed at reducing recurrence and improving women's quality of life.
Authors
- Gilberto dos Santos Póvoas Júnior
- Dayane Santos Silva
- Vinicius Ribeiro de Oliveira
- Sabrina Costa Oliveira Laudisse
- Mariana Thomé de Morais Puerta
Publication Details
- Journal
- Revista fisio&terapia.
- Published
- 2026-11-16
- DOI
- https://doi.org/10.69849/28chqb81
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00